Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
“It isn’t easy to kick this… Because porn shrinks your world.” —Aline Zoldbrod, PhD
Family Medicine/General Practice April 1st 2025
Verywell Health
“It’s absolutely not nature’s Ozempic and does not work like Ozempic, which is a GLP-1 inhibitor. Manufacturers of these supplements are just kind of creating a hype…”
Clinical Pharmacology March 31st 2025
Medical News Today (MNT)
“We are recommending that if patients are starting these drugs or increasing the dose of these drugs, they should do so slowly to reduce the risk of dropping their blood sugar and causing an osmotic shift.”
Endocrinology, Diabetes, Metabolism February 21st 2025
Women’s Healthcare
The study demonstrated a reduced risk of suicidal thoughts and self-harm among people using GLP-1 drugs.
Clinical Pharmacology February 11th 2025
Annals of Internal Medicine
In a systematic review of 26 randomized controlled trials involving over 15,000 participants, tirzepatide demonstrated weight reduction of 17.8% at 72 weeks, while newer agents like retatrutide achieved up to 22.1% reduction at 48 weeks, providing clinicians with expanded options for pharmacological weight management.
Endocrinology, Diabetes, Metabolism February 6th 2025
Infectious Disease Advisor
The preservation of Medicare drug price negotiations alongside the removal of other cost-reduction measures creates a complex landscape for healthcare delivery and patient access.
All Specialties February 6th 2025